Skip to main content
P&T COMMUNITY
Register
Sign in
Search form
Search
Home
News
P&T
Current issue
Past issues
Contact us
Digital Edition
Subscribe
P&T TV
Dr. David B. Nash
Meeting Highlights
Authors
About
Contact Us
News
P&T Journal
Formulary Kits
INGREZZA®
(valbenazine) tablets
KEDRAB™
(Rabies Immune Globulin [Human])
LOKELMA™
(sodium zirconium cyclosilicate) 10 g for oral suspension
PERSERIS™
(risperidone) for extended-release injectable suspension
SUBLOCADE™
(buprenorphine extended-release) Injection for Subcutaneous Use (CIII)
Please
click
for full Prescribing Information, including Boxed Warning.
You are here
Home
News by month %2 2018
News by month August 2018
PTCommunity News August 2018
Better Access to Diabetes Drugs for Medicaid Beneficiaries Under ACA
Seventeen Companies Stop Sales of E-Liquids with Kid-Friendly Advertising
FDA Approves First Drug for Neurotrophic Keratitis
How Can Medicare Save A Billion Bucks? Use Generics
CMS Tightens Oversight of Medicaid Demonstration Project Costs
FDA Approves First Generic Version of EpiPen
FDA Permits Marketing of Transcranial Magnetic Stimulation for Treatment of Obsessive Compulsive Disorder
Around the Country, States Pass Bills to Curb Drug Costs
DOJ and DEA Propose Lowering Opioid Production Quotas by 10% in 2019
New Vaginal Ring Approved for An Entire Year of Birth Control
New Targeted RNA-based Infusion to Treat Rare Polyneuropathy in Adults
FDA Approves Galafold for Fabry Disease in Adults
Predicting the Risk for Five Deadly Diseases
Disappointing Results for Some Workplace Wellness Programs
Increased Risk of Cancer Relapse with Long-term Use of Azithromycin
FDA Takes Steps to Encourage Development of Opioid Addiction Drugs
Women Are Ten Times More Likely to Get Tested for BRCA1 and BRCA2
